$11.43
0.615.64%
Últ. Act.: Oct 21, 5:37 AM
$11.44
0.625.73%
Novavax (NVAX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Novavax (NVAX) publicó su última previsión de agosto 6, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $235M - $275M para el período.
En comparación con la previsión anterior, Novavax elevado redujo su previsión de ingresos desde un rango anterior de $230M - $270M.
Novavax ha emitido 18 actualizaciones de orientación entre el noviembre 8, 2022 y el agosto 6, 2026. During this period, the company raised its outlook 5 times and lowered it 9 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.37 | $-0.23 | $-0.56 | $-0.96 |
| Actual | $-0.32 | $-0.06 | $0.11 | $-0.48 |
| Surprise | +13.5% | +73.9% | +119.6% | +50.0% |
| Revenue | ||||
| Estimate | $51.7M | $76.9M | $85.5M | $42.8M |
| Actual | $56.7M | $139.5M | $147.1M | $70.4M |
| Surprise | +9.76% | +81.5% | +72.0% | +64.7% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.24 | $-0.01 | $-0.27 | $0.13 |
| Revenue | ||||
| Consensus | $69.8M | $110.6M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.32 | $-0.37 | 13.5 % |
| Q1 | May 6, 2026 | $-0.06 | $-0.23 | 73.9 % |
| Q4 | Feb 26, 2026 | $0.11 | $-0.56 | 119.6 % |
| Q3 | Nov 6, 2025 | $-0.48 | $-0.96 | 50.0 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $56.70M | $51.66M | 9.76 % |
| Q1 | May 6, 2026 | $139.51M | $76.87M | 81.5 % |
| Q4 | Feb 26, 2026 | $147.14M | $85.52M | 72.0 % |
| Q3 | Nov 6, 2025 | $70.44M | $42.77M | 64.7 % |